Dr. Kimberly Negrin is a scientist with an entrepreneurial spirit and passion for building business relationships. She is an accomplished strategy and business operations leader in the cell and gene therapy (CGT) industry. Prior to joining Stoic Bio, Dr. Negrin played a leadership role for HemaCare (a Charles River company) overseeing and supporting clients as they mature through research, clinical, and commercial development of novel engineered and manufactured cell therapy products and applications. She previously worked at Agilent Technologies and Seahorse Bioscience. Dr. Negrin completed her doctoral training at UMass Medical School in the Department of Molecular Medicine, where she earned her Ph.D. in Biomedical Science.